Read by QxMD icon Read

erythropoetin in jehovah witness

Kristina Gebhardt, Christine Bartsch
A 39-year-old man and Jehova's Witness suffered a complex pelvic fracture in an accident at work. He died 17 days later from fulminant pulmonary embolism. For religious reasons he had refused blood transfusions which would have been necessary for an early surgical stabilization of the pelvic fracture. Alternatively, the clinicians initiated a therapy with recombinant human erythropoetin (EPO) to increase haemoglobin and postponed the surgical stabilization of the pelvic fracture to a later date. Shortly before the planned operation, the patient suddenly died...
November 2009: Archiv Für Kriminologie
Jose Figueiro, Anil Vaidya, Gaetano Ciancio, Les Olson, Joshua Miller, George W Burke
The safety and efficacy of renal and liver transplantation has been reported for Jehovah's Witness (JW) patients, with patient, and graft survival similar to that of non-JW patients. We report our experience in five JW recipients of simultaneous pancreas-kidney transplants. None of the patients received transfusion of blood or blood products, either before or after transplant. Like the other solid organ transplants, patient, and graft survival was similar to that of the non-JW group. Specific technical issues related to the operative procedure include the use of the cell saver until the donor duodenum is opened (enteric contamination)...
April 2003: Clinical Transplantation
U Atabek, R Alvarez, M J Pello, J B Alexander, R C Camishion, C Curry, R K Spence
UNLABELLED: We evaluated the role of recombinant human erythropoietin (RHE) for treatment of severe postsurgical anemia (Hct < 25%) in 40 Jehovah's Witness (JW) patients refusing transfusion. Twenty patients (group E) received RHE either at a loading dose of 300 U/kg iv 3 times/week for 1 week followed by 150 U/kg 3 times/week in accordance with an IRB approved protocol (N = 13), or at a dose of 100 U/kg 3 times/week for humanitarian reasons (N = 7). This group was compared to 20 similar JW patients who did not receive RHE (group C)...
January 1995: American Surgeon
P M Vogt, K Kurz-Müller, F W Peter, R Büttemeyer, M Tryba, H U Steinau
The treatment rationale of a burn victim (35% TBSA) who was child of Jehova's witnesses is described. Following a combined approach including erythropoetin and blood saving surgical techniques we were able to excise and graft the burn areas without blood transfusion. An extremely low hemoglobin of 3.4 g/dl was tolerated postoperatively and showed an increase to 10.9 g/dl 25 days later when the child was dismissed from the burn unit in stable condition. Possibilities to minimize blood loss and to avoid blood transfusions are discussed...
November 1994: Der Chirurg; Zeitschrift Für Alle Gebiete der Operativen Medizen
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"